Annual CFO
-$73.31 M
-$2.18 M-3.06%
31 December 2023
Summary:
Humacyte annual cash flow from operations is currently -$73.31 million, with the most recent change of -$2.18 million (-3.06%) on 31 December 2023. During the last 3 years, it has fallen by -$17.74 million (-31.92%). HUMA annual CFO is now -31.92% below its all-time high of -$55.57 million, reached on 31 December 2020.HUMA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$22.91 M
-$1.62 M-7.59%
30 September 2024
Summary:
Humacyte quarterly cash flow from operations is currently -$22.91 million, with the most recent change of -$1.62 million (-7.59%) on 30 September 2024. Over the past year, it has dropped by -$9.90 million (-76.11%). HUMA quarterly CFO is now -76.11% below its all-time high of -$13.01 million, reached on 30 September 2023.HUMA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$90.60 M
-$9.90 M-12.27%
30 September 2024
Summary:
Humacyte TTM cash flow from operations is currently -$90.60 million, with the most recent change of -$9.90 million (-12.27%) on 30 September 2024. Over the past year, it has dropped by -$17.39 million (-23.75%). HUMA TTM CFO is now -522.97% below its all-time high of -$14.54 million, reached on 31 March 2021.HUMA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HUMA Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.1% | -76.1% | -23.8% |
| 3 y3 years | -31.9% | +24.9% | -51.6% |
| 5 y5 years | - | - | - |
HUMA Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -31.9% | +9.7% | -76.1% | +24.9% | -51.6% | at low |
| 5 y | 5 years | -31.9% | +9.7% | -76.1% | +24.9% | -523.0% | at low |
| alltime | all time | -31.9% | +9.7% | -76.1% | +24.9% | -523.0% | at low |
Humacyte Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$22.91 M(+7.6%) | -$90.60 M(+12.3%) |
| June 2024 | - | -$21.29 M(-22.1%) | -$80.70 M(-1.6%) |
| Mar 2024 | - | -$27.35 M(+43.5%) | -$82.01 M(+11.9%) |
| Dec 2023 | -$73.31 M(+3.1%) | -$19.05 M(+46.5%) | -$73.31 M(+0.1%) |
| Sept 2023 | - | -$13.01 M(-42.5%) | -$73.21 M(-4.9%) |
| June 2023 | - | -$22.60 M(+21.3%) | -$77.01 M(+8.5%) |
| Mar 2023 | - | -$18.64 M(-1.7%) | -$70.97 M(-0.2%) |
| Dec 2022 | -$71.13 M | -$18.96 M(+12.8%) | -$71.13 M(-3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$16.80 M(+1.4%) | -$73.62 M(-15.7%) |
| June 2022 | - | -$16.57 M(-11.9%) | -$87.33 M(+2.2%) |
| Mar 2022 | - | -$18.80 M(-12.4%) | -$85.44 M(+5.2%) |
| Dec 2021 | -$81.19 M(+46.1%) | -$21.45 M(-29.7%) | -$81.19 M(+35.9%) |
| Sept 2021 | - | -$30.52 M(+107.9%) | -$59.74 M(+104.4%) |
| June 2021 | - | -$14.68 M(+0.9%) | -$29.22 M(+100.9%) |
| Mar 2021 | - | -$14.54 M | -$14.54 M |
| Dec 2020 | -$55.57 M | - | - |
FAQ
- What is Humacyte annual cash flow from operations?
- What is the all time high annual CFO for Humacyte?
- What is Humacyte annual CFO year-on-year change?
- What is Humacyte quarterly cash flow from operations?
- What is the all time high quarterly CFO for Humacyte?
- What is Humacyte quarterly CFO year-on-year change?
- What is Humacyte TTM cash flow from operations?
- What is the all time high TTM CFO for Humacyte?
- What is Humacyte TTM CFO year-on-year change?
What is Humacyte annual cash flow from operations?
The current annual CFO of HUMA is -$73.31 M
What is the all time high annual CFO for Humacyte?
Humacyte all-time high annual cash flow from operations is -$55.57 M
What is Humacyte annual CFO year-on-year change?
Over the past year, HUMA annual cash flow from operations has changed by -$2.18 M (-3.06%)
What is Humacyte quarterly cash flow from operations?
The current quarterly CFO of HUMA is -$22.91 M
What is the all time high quarterly CFO for Humacyte?
Humacyte all-time high quarterly cash flow from operations is -$13.01 M
What is Humacyte quarterly CFO year-on-year change?
Over the past year, HUMA quarterly cash flow from operations has changed by -$9.90 M (-76.11%)
What is Humacyte TTM cash flow from operations?
The current TTM CFO of HUMA is -$90.60 M
What is the all time high TTM CFO for Humacyte?
Humacyte all-time high TTM cash flow from operations is -$14.54 M
What is Humacyte TTM CFO year-on-year change?
Over the past year, HUMA TTM cash flow from operations has changed by -$17.39 M (-23.75%)